01.12.2016 19:19:27
|
Heat Biologics Posting Substantial Loss In Afternoon Trading
(RTTNews) - Biotechnology company Heat Biologics (HTBX) is posting a substantial loss in afternoon trading on Thursday, plunging by 61 percent. Shares of Heat Biologics are pulling back further off the ten-month closing high set on Monday.
The sell-off by Heat Biologics comes following disappointing results from its phase II study of bladder cancer cell vaccine HS-410 in the treatment of non-muscle invasive bladder cancer.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Heat Biologics Incmehr Nachrichten
Keine Nachrichten verfügbar. |